| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/28/2005 | WO2005037765A1 CATALYTIC α-ALKYLATION OF ALDEHYDES AND KETONES |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037282A1 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists |
| 04/28/2005 | WO2005037281A1 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037227A2 Selective cox-2 inhibitors |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005037206A2 Anti-cancer compounds and methods of use thereof |
| 04/28/2005 | WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2005004796A3 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 04/28/2005 | WO2004106299A3 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 04/28/2005 | WO2004083170A3 Compounds, a process for their preparation and their use as dyes and pigments |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090664 comprises optionally supported raney catalysts; for production of cleaning compositions |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090542 crystalline polymorphic dosage forms of anticholesterol agents; statins |
| 04/28/2005 | US20050090540 E.g., 2,2-bis(hydroxymethyl)-1 -azabicyclo[2,2,2]octan-3-one and 2-hydroxymethyl-3,3-dihydroxy-1-azabicyclo[2,2,2]octane; these compounds reactivate the apoptosis-inducing function of mutant p53 proteins and are used to treat various types of tumors |
| 04/28/2005 | US20050090539 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090469 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | US20050087101 Preparing an ink jet ink composition by contacting the resulting lactam with colorant(s); efficient, one step low cost process |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542727A1 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/28/2005 | CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524977A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/27/2005 | EP1373202B1 Preparation of non-crystalline atorvastatin calcium |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | EP0873519A4 Hiv protease inhibitors |
| 04/27/2005 | CN1610678A Pyrrolidone carboxamides |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610660A Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/27/2005 | CN1610657A Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3, 5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 04/27/2005 | CN1198839C Novel dipeptide amidines as thrombin inhibitors |
| 04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198800C 2-(2-chlorophenyl)-3,4-dihydro-2H-pyrrol derivs. |
| 04/26/2005 | US6884874 Such as n-methyl-alanine derivatives; for preparing antibody/maytansinoid complexes |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | CA2280137C Sizing of paper |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | WO2005034878A2 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/21/2005 | WO2004110995A8 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 04/21/2005 | WO2004094375A3 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085655 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/21/2005 | US20050085636 Reacting organoboron compound with oxypiperidine compound |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085474 difluoroamine compounds |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085449 Antidepressants; sexual disorders; osteoporosis; alopecia; anemia; benign prostate hyperplasia; anticancer agents |
| 04/21/2005 | CA2542077A1 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | CA2542012A1 A method for producing aminopyrrolidine derivatives and intermediate compounds |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/20/2005 | EP1524265A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors |
| 04/20/2005 | EP1523472A1 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 04/20/2005 | EP0721455B9 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 04/20/2005 | CN1197847C Compound N-total trans dimension methanamide derivative and its preparation method and application |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | WO2005033078A1 Process for the production of atorvastatin calcium |
| 04/14/2005 | WO2005033076A1 Method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 04/14/2005 | WO2005032541A1 Substituted heterocyclic mercaptosulfide inhibitors |
| 04/14/2005 | WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/14/2005 | WO2005032464A2 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 04/14/2005 | WO2005000815A3 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/14/2005 | WO2004098525A3 Uses of ion channel modulating compounds |
| 04/14/2005 | WO2004069796A8 Process for producing levetiracetam |
| 04/14/2005 | WO2003090678A3 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 04/14/2005 | US20050080271 Peptidomimetic ligands for cellular receptors and ion channels |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080126 Sulpiride pharmaceutical compositions |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | CA2540452A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/14/2005 | CA2540061A1 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 04/13/2005 | EP1521743A1 Hmg-coa reductase inhibitors |